Bristol-Myers Squibb has got its $14 billion acquisition of Karuna Therapeutics over the line, having had to withdraw and refile antitrust paperwork and contend with a shareholder lawsuit that tried ...
Karuna Therapeutics said this morning that the FDA has formally started its review of KarXT, aiming to become the first drug to reach the market for schizophrenia with a new mechanism of action in ...
The UK government has imposed sanctions on four individuals responsible for serious human rights abuses and violations during the Sri Lanka civil war; including extrajudicial killings, torture and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results